Skip to content

Released Feb 25, 2021, after the close

10-K filed Feb 25, 2021, 56 days after period end · 0001636422-21-000026

Q4 2020 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$53.28Mderived+22.5% vs Q4 2019+12.9% vs Q3 2020
Net Income-$43.02MderivedN/M vs Q4 2019N/M vs Q3 2020
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$38,922,000N/M
Operating Cash Flowderived-$4,141,000N/M
Free Cash Flowderived-$10,596,000N/M
Margins · derived
Operating margin-73.1%−41.6 pt vs Q4 2019
Net margin-80.7%−47.9 pt vs Q4 2019

What the release said

The release

Same quarter

MetricQ4 2020derived from reported figuresQ4 2019derived from reported figuresQ4 2018derived from reported figures
Revenue$53.28M$43.50M—
Net Income-$43.02M-$14.27M—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR